Watanabe H, Ichihara E, Kayatani H, Makimoto G, et al. VEGFR2 blockade augments the effects of tyrosine kinase inhibitors by inhibiting angiogenesis and oncogenic signaling in oncogene-driven non-small-cell lung cancers. Cancer Sci 2021;112:1853-1864.
PMID: 33410241